Ivermectin’s popularity can be traced, in large part, to two men: Dr. Pierre Kory, a former critical-care specialist at the University of Wisconsin, and Dr. Paul Marik, the former chief of critical care at Eastern Virginia Medical School. The duo formed the FLCCC in April 2020, along with six other doctors and two former journalists.
Office of Strategic Communication